intranasal glutathione Safety Survey of GSH Science & Research |

The interest is legitimate and the animal data is compelling, but intellectual honesty requires acknowledging that compelling animal data has failed to translate to human benefit in many prior pharmacological contexts

Volitinib, a potent and highly selective c-Met inhibitor, effectively blocks c-Met signaling and growth in c-MET amplified gastric cancer patient-derived tumor xenograft models

Pharmacological treatments are reserved for specific circumstances and limited to licensed medications with demonstrated efficacy and safety profiles, such as orlistat or semaglutide (NICE TA875)

Evidence shows collagen synthesis, actin remodeling, and cell migration support systemic tissue repair and recovery